Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

MAKING DIABETES A CURABLE ILLNESS

Harvard University scientists have linked a newly discovered hormone they’ve named fabkin to the onset of diabetes and found a way to neutralize it, preventing and even reversing the disease in mice.
They found the new hormone by tracking a protein called FAB4 on its journey through the body. Fat cells release the protein into the bloodstream when a person is starving.
The researchers saw that when FAB4 enters the bloodstream, it binds with two enzymes to create the fabkin hormone. The binding process alters the way the enzymes work, which reduces blood levels of ATP and ADP, which are essential in breaking down and processing nutrients.
Nearby cells react to these changes, which can be particularly damaging to insulin-producing cells in the pancreas.
People with types 1 and 2 diabetes have abnormally high levels of FAB4 in their blood, leading the researchers to make the connection among FAB4, fabkin, and diabetes.
When the scientists treated diabetic mice with a biochemical reducing levels of FAB4 in their blood, the disease disappeared; in mice at risk of diabetes, the treatment prevented diabetes from taking hold.
TRENDPOST: Scientists continue to find ways to use the body’s own compounds to counter disease. As a result, future generations will be far less reliant on synthetic pharmaceuticals, seeing them, with their noxious side effects, as a last resort instead of a first choice.

Comments are closed.